cancer

Will Big Pharma Cancer Drug Collaborations Set The Stage For Lower Drug Costs?
Forbes
Mon, 06/1/15 - 12:20 pm
cancer
Big Pharma
drug pricing
Novartis, Celgene meds take the biggest shares of cancer drug spending
Fierce Pharma
Thu, 05/28/15 - 01:56 pm
Novartis
Celgene
cancer
Post-swap Novartis preps cancer drug R&D road show
Fierce Biotech
Wed, 05/27/15 - 11:26 am
Novartis
R&D
cancer
Tafinlar
Mekinist
GSK
ASCO
CEO of cancer vax rising star Bavarian Nordic: We are not for sale
BioPharma Dive
Wed, 05/27/15 - 11:07 am
M&A
cancer
cancer vaccines
Bavarian Nordic
Paul Chaplin
The FierceBiotech panel: Top research execs tackle the fast-changing field of cancer drug R&D
Fierce Biotech
Mon, 05/18/15 - 10:04 pm
biotech
cancer
R&D
10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15
TheStreet.com
Fri, 05/15/15 - 11:05 am
ASCO
cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Genentech
MPDL3280A
MEDI4736
AstraZeneca
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
Is Novartis an Up-and-Coming Oncology Powerhouse?
Yahoo/Market Realist
Wed, 05/6/15 - 08:51 am
Novartis
oncology
cancer
Global cancer drug spending hits $100 billion in 2014-IMS Health
Yahoo/Reuters
Tue, 05/5/15 - 08:41 am
cancer
drug spending
Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors
Forbes
Mon, 05/4/15 - 08:54 am
Lynparza
cancer
BRCA
Celgene bags a build-to-buy biotech in $485M cancer deal
Fierce Biotech
Mon, 04/27/15 - 09:49 am
Celgene
M&A
Quanticel Pharmaceuticals
cancer
R&D
FDA review challenges Amgen on a questionable T-Vec study
Fierce Biotech
Mon, 04/27/15 - 09:46 am
FDA
Amgen
T-Vec
Talimogene Laherparepvec
cancer
cancer vaccines
ThromboGenics spins out Roche-rejected cancer drug
Fierce Biotech
Thu, 04/16/15 - 09:59 am
ThromboGenics
Roche
TB-403
cancer
A CEO's View On Cancer, Virus-Based 'Cures,' And '60 Minutes' Vs. Reality
Forbes
Wed, 04/8/15 - 11:02 am
cancer
Oncolytics
Brad Thompson
New cancer drugs "vastly overestimated", says contrarian analyst
Yahoo/Reuters
Tue, 03/31/15 - 12:46 pm
cancer
PD-1 inhibitors
PDL-1 inhibitors
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Investors Bet $100,000 Cancer Drug Prices Are Here to Stay
Bloomberg
Mon, 03/9/15 - 12:26 pm
drug pricing
cancer
Keytruda
Opdivo
Imbruvica
Global cancer drug market to grow to $111 billion by 2020: report
Medical Marketing and Media
Tue, 02/24/15 - 05:02 pm
cancer
cancer immunotherapy
Merck
Bristol-Myers Squibb
PD-1 inhibitors
Novartis AG wins approval to buy GSK cancer drugs with conditions
Yahoo/Reuters
Mon, 02/23/15 - 06:00 pm
Novartis
GSK
cancer
BRAF inhibitor
MEK inhibitor
Is Revlimid Becoming a Catch-All Cancer Drug?
24/7 Wall St
Thu, 02/19/15 - 07:54 am
Revlimid
Celgene
Multiple Myeloma
cancer
Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
cancer
CAR-T
Amgen
Celgene
Bluebird Bio
Novartis
Kite Pharma
Pfizer
Cellectis
Juno Therapeutics

Pages